Skip to main content
Clinical Trials/NL-OMON30845
NL-OMON30845
Withdrawn
Not Applicable

a pilot study into the effects and feasibility of the use of Tiscover® (tissue-engineered autologous skin substitute) for chronic ulcers (venous ulcers, diabetic ulcers and decubitus ulcers). - Effects of Tiscover® on chronic ulcers

Vrije Universiteit Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
decubitus/diabetic/ venous ulcers
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
20
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • · Venous ulcer, arterio(lo)sclerotic ulcer , decubitus ulcer or diabetic ulcer .
  • · chronic (\>1 month no tendency to heal),
  • · Ulcer 1\-100 cm²
  • · consent (competent)
  • · Ulcus depth \< 1\.0 cm

Exclusion Criteria

  • \- serious comorbidity (lief expectancy \< 6 months)
  • \- use of high dose corticosteroids or cytostatics
  • \- allergy for penicillin
  • \- serious wound infection at t\=0
  • \- refusal of necessary clinical treatments
  • \- incompetent for decision making

Outcomes

Primary Outcomes

Not specified

Similar Trials